INO Long Put Strategy

INO (Inovio Pharmaceuticals, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.

Inovio Pharmaceuticals, Inc. is a biotechnology firm dedicated to the research, development, and market introduction of DNA-based treatments. Its core mission is to prevent and cure illnesses associated with human papillomavirus (HPV), various types of cancer, and infectious diseases. The company's advanced DNA medicine platform utilizes meticulously engineered SynCon sequences to precisely identify and optimize the genetic blueprint of a target antigen. This innovative approach is supported by its CELLECTRA smart device technology, which efficiently delivers the DNA plasmids. Inovio is actively engaged in and planning clinical trials for its DNA medicines across a wide array of conditions. These include HPV-related precancerous lesions, such as cervical, vulvar, and anal dysplasia; HPV-driven cancers affecting areas like the head and neck, cervix, anus, penis, vulva, and vagina; and other HPV-associated disorders like recurrent respiratory papillomatosis.

INO (Inovio Pharmaceuticals, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $58.9M, a beta of 1.47 versus the broader market, a 52-week range of 1.03-2.98, average daily share volume of 2.8M, a public-listing history dating back to 1998, approximately 134 full-time employees. These structural characteristics shape how INO stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 1.47 indicates INO has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.

What is a long put on INO?

A long put buys downside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes below the strike minus premium at expiration.

Current INO snapshot

As of June 29, 2026, spot at $1.13, ATM IV 245.15%, IV rank 49.34%, expected move 70.28%. The long put on INO below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 32-day expiry.

Why this long put structure on INO specifically: INO IV at 245.15% is mid-range versus its 1-year history, so strategy selection should anchor more to the directional thesis than to the IV regime, with a market-implied 1-standard-deviation move of approximately 70.28% (roughly $0.79 on the underlying). The 32-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated INO expiries trade a higher absolute premium for lower per-day decay. Position sizing on INO should anchor to the underlying notional of $1.13 per share and to the trader's directional view on INO stock.

INO long put setup

The INO long put below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With INO near $1.13, the first option leg uses a $1.13 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed INO chain at a 32-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 INO shares for the stock leg in covered calls and collars).

ActionTypeStrike / BasisPremium (est)
Buy 1Put$1.13N/A

INO long put risk and reward

Net Premium / Debit
N/A
Max Profit (per contract)
Unbounded
Max Loss (per contract)
Unbounded
Breakeven(s)
None on modeled curve
Risk / Reward Ratio
N/A

Max profit equals the strike minus premium times 100 (reached at zero); max loss equals the premium times 100. Breakeven is strike minus premium.

INO long put payoff curve

Modeled P&L at expiration across a range of underlying prices for the long put on INO. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

When traders use long put on INO

Long puts on INO hedge an existing long INO stock position or express a bearish view with defined risk; position sizing typically scales the put notional to the underlying INO exposure being hedged.

INO thesis for this long put

The market-implied 1-standard-deviation range for INO extends from approximately $0.34 on the downside to $1.92 on the upside. A INO long put expresses a directional view that the underlying closes below the strike minus premium at expiration, frequently sized to hedge an existing long INO position with one put per 100 shares held. Current INO IV rank near 49.34% is mid-range against its 1-year distribution, so the IV signal is neutral; the long put thesis on INO should anchor more to the directional view and the expected-move geometry. As a Healthcare name, INO options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to INO-specific events.

INO long put positions are structurally bearish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. INO positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move INO alongside the broader basket even when INO-specific fundamentals are unchanged. Long-premium structures like a long put on INO are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current INO chain quotes before placing a trade.

Frequently asked questions

What is a long put on INO?
A long put on INO is the long put strategy applied to INO (stock). The strategy is structurally bearish: A long put buys downside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes below the strike minus premium at expiration. With INO stock trading near $1.13, the strikes shown on this page are snapped to the nearest listed INO chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are INO long put max profit and max loss calculated?
Max profit equals the strike minus premium times 100 (reached at zero); max loss equals the premium times 100. Breakeven is strike minus premium. For the INO long put priced from the end-of-day chain at a 30-day expiry (ATM IV 245.15%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a INO long put?
The breakeven for the INO long put priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current INO market-implied 1-standard-deviation expected move is approximately 70.28%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a long put on INO?
Long puts on INO hedge an existing long INO stock position or express a bearish view with defined risk; position sizing typically scales the put notional to the underlying INO exposure being hedged.
How does current INO implied volatility affect this long put?
INO ATM IV is at 245.15% with IV rank near 49.34%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.

Related INO analysis